<html>
<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 14 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Lucida Grande";}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:18.0pt;
	margin-left:0cm;
	font-size:14.0pt;
	font-family:"Arial","sans-serif";}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:12.0pt;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:9.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Helvetica","sans-serif";
	color:black;
	text-decoration:underline;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-weight:normal;
	font-style:italic;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:9.0pt;
	font-family:"Lucida Grande","sans-serif";}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Lucida Grande","sans-serif";}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Helvetica","sans-serif";
	color:black;
	font-weight:bold;
	text-decoration:underline;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";
	font-family:"Arial","sans-serif";}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-style:italic;}
span.UnresolvedMention1
	{mso-style-name:"Unresolved Mention1";
	color:#605E5C;
	background:#E1DFDD;}
span.glyph8
	{mso-style-name:glyph8;
	font-family:"Times New Roman","serif";}
p.bulletindent12, li.bulletindent12, div.bulletindent12
	{mso-style-name:bulletindent12;
	margin-top:10.8pt;
	margin-right:0cm;
	margin-bottom:10.8pt;
	margin-left:24.0pt;
	line-height:140%;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
span.nowrap1
	{mso-style-name:nowrap1;}
span.h33
	{mso-style-name:h33;
	font-weight:bold;}
span.headingendmark
	{mso-style-name:headingendmark;}
span.h23
	{mso-style-name:h23;
	font-weight:bold;}
.MsoChpDefault
	{font-size:10.0pt;
	font-family:"Tahoma","sans-serif";}
 /* Page Definitions */
 @page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
</head>
<body lang=EN-GB link=blue vlink=purple>
<div class=WordSection1>
<h2><span style='font-size:14.0pt;color:black'>Cellulitis</span></h2>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal><span style='color:black'>The term cellulitis is commonly
used to indicate a non-necrotizing inflammation of the skin and subcutaneous
tissues, usually from acute infection. Cellulitis usually follows a breach in
the skin, although a portal of entry may not be obvious; the breach may involve
microscopic skin changes or invasive qualities of certain bacteria.</span></p>
<h2><span lang=EN-US>Target Users</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<h2><span lang=EN-US>Target area of use </span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient department</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Gate clinic</span></p>
<h2><span lang=EN-US>Key areas of focus/new additions/changes</span></h2>
<p class=MsoNormal><span lang=EN-US>These guidelines addresses the management of
cellulitis in adults and children.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>Patient with complicated cellulitis
associated with compartment syndrome or necrosis must be referred to a surgeon.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span style='color:black'>Presenting symptoms and signs</span></h2>
<p class=MsoNormal><span style='color:black'>Nonpurulent cellulitis is
associated with the 4 cardinal signs of infections, as follows:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Erythema</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Pain</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Swelling</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Warmth</span></p>
<p class=MsoNormal><span style='color:black'>The follow findings suggest severe
infection:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Malaise</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Chills</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Fever and toxicity</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Circumferential cellulitis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Lymphangitic spread (red lines
streaking away from the area of infection)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Crepitus</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Pain disproportionate to examination
findings</span></p>
<h2 style='margin-bottom:6.0pt'><span style='color:black'>Examination findings</span></h2>
<p class=MsoNormal>The involved site(s) is/are red, hot, swollen and tender. The
leg is the most common site. Tinea pedis lesions may be the sites of entry</p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Regional lymphadenopathy may be present</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Malaise, chills, fever, and toxicity may be present</p>
<p class=MsoNormal>Skin infections without associated drainage, penetrating
trauma, eschar, or abscess is most likely caused by streptococci; on the other
hand<b>, <i>S aureus</i></b>, often community acquired methicillin-resistant <i>S
aureus </i>(MRSA), is the most likely pathogen when these factors are present.</p>
<p class=MsoNormal>Perianal cellulitis is usually observed in children with
perianal fissures; it is characterized by <b>perianal erythema</b> and <b>pruritis,
purulent secretions</b>, <b>painful defecation </b>and <b>blood in stools</b></p>
<p class=MsoNormal>Cellulitis characterized by violet colour and bullae
suggests more serious or systemic infection with organisms such as<b> </b><i>V.
vulnificus</i> or <i>S. pneumoniae.</i></p>
<p class=MsoNormal>Lymphangitic spread (red lines streaking away from area of
infection), crepitus, .and hemodynamic instability are indications of severe
infection, requiring more aggressive treatment.</p>
<p class=MsoNormal>Circumferential cellulitis or pain that is disproportional
to examination findings should prompt consideration of severe soft tissue
infection</p>
<p class=MsoNormal><span lang=EN-US><a
href="https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540402/all/Orbital_Cellulitis"><b><span
lang=EN style='color:windowtext;text-decoration:none'>Periorbital</span></b></a></span><b><span
lang=EN> (preseptal) cellulitis </span></b><span lang=EN> is potentially
serious and merits an ophthalmology consultation and a CT scan to exclude an
orbital infection</span></p>
<p class=MsoNormal><b><u><span style='color:black'>Indication for referral for emergent
surgical evaluation</span></u></b><span style='color:black'> are as follows:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Violaceous bullae</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Cutaneous haemorrhage</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Skin sloughing</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Skin anaesthesia</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Rapid progression</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Gas in the tissue (crepitus)</span></p>
<h2><span style='color:black'>Differential Diagnoses</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Erysipelas (more superficial with
sharply demarcated borders)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN style='color:black'>Thrombophlebitis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US><a
href="https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540378/all/Necrotizing_Fasciitis"><span
lang=EN style='color:black;text-decoration:none'>Necrotizing fasciitis</span></a></span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN style='color:black'>Erythroderma</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN style='color:black'>Panniculitis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN style='color:black'>Pyoderma</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN style='color:black'>Dermatitis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN style='color:black'>Allergic reactions</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN style='color:black'>Drug reaction </span></p>
<h2><span style='color:black'>Investigations</span></h2>
<p class=MsoNormal><span lang=EN style='color:black'>Generally no work-up is required
in uncomplicated cases of cellulitis.</span></p>
<p class=MsoNormal><span lang=EN style='color:black'>For patients with cellulitis
who have signs and symptoms of systemic inflammatory response, do:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>FBC </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Creatinine and Bicarbonate </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Aspirate gram stain and culture
(purulent cellulitis only)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Blood culture should be performed for
serious infections to pinpoint the etiology </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:36.0pt'><span
style='color:black'>Blood cultures are only positive in 5-15 % of patients with
cellulitis)</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt'><span
style='color:black'>Blood cultures are also indicated in special populations (immunosuppressed,
severe post-surgical wounds</span><span style='color:black'>).</span></p>
<h2><span style='color:black'>Management </span></h2>
<h3>Management at the Gate Clinic</h3>
<p class=MsoNormal><span style='color:black'>Patients with cellulitis should be
referred to OPD for evaluation by a doctor.</span></p>
<h3>Management in OPD or on the ward</h3>
<p class=MsoNormal><span style='color:black'>Management of cellulitis should
include elevation of the affected area and treatment of underlying conditions. </span></p>
<p class=MsoNormal><span style='color:black'>Many patients with cellulitis have
underlying conditions that predispose them to developing recurrent cellulitis
(these include tinea pedis, lymphedema, and chronic venous insufficiency). In
such patients, treatment should be directed at both the infection and the
predisposing condition if modifiable. As an example, patients with oedema may
benefit from treatment with compressive stockings and diuretic therapy. </span></p>
<p class=MsoNormal><span style='color:black'>Consider in-patient care when
there is:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>An elevated creatinine level</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>A low serum bicarbonate level</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Systemic signs of toxicity (e.g. fever
&gt; 38°C, hypotension, or sustained tachycardia)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Rapid progression of erythema</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Progression of clinical findings after
48 hours of oral antibiotic therapy</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Inability to tolerate oral therapy</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Proximity of the lesion to an
indwelling medical device (e.g. prosthetic joint or vascular graft)</span></p>
<h3>Nonpurulent cellulitis</h3>
<p class=MsoNormal><span lang=EN-US>Patients with nonpurulent cellulitis (e.g.
cellulitis with no purulent drainage or exudate and no associated abscess)
should be managed with empiric therapy for infection due to beta-hemolytic
streptococci and methicillin-susceptible </span><em><span lang=EN-US
style='font-family:"Arial","sans-serif";color:black'>Staphylococcus aureus</span></em><span
lang=EN-US>. Common options for mild infections are:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='color:black'>Cloxacillin 25 mg/kg/dose (max.
500 mg) PO QDS</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='color:black'>Amoxicillin/Clavulanate 625
– 875 mg PO BD </span></p>
<p class=MsoNormal><span lang=EN-US style='color:black'>For patients with
penicillin allergies:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='color:black'>Azithromycin 10 mg/kg (max.
500 mg) PO OD for 3 days, or</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='color:black'>Clindamycin 150 – 300 mg PO QDS
(3 – 6 mg/kg/dose in children)</span></p>
<p class=MsoNormal><span lang=EN-US style='color:black'>In patients with
moderately severe infection, intravenous antibiotics options include:</span></p>
<p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='color:black'>IV Cloxacillin 1 – 2 g QDS</span></p>
<p class=MsoNormal><span lang=EN-US style='color:black'>For severe infections:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='color:black'>IV Ceftriaxone 1 – 2 g OD
(children 50 – 80 mg/kg OD)</span></p>
<p class=MsoListParagraphCxSpLast><span lang=EN-US style='color:black'>&nbsp;</span></p>
<h3><span class=h23>Purulent infection</span></h3>
<p class=MsoNormal><span lang=EN-US style='font-family:"Helvetica","sans-serif";
color:black'>Purulent infection refers to presence of a drainable abscess <strong><span
style='font-family:"Helvetica","sans-serif"'>or</span></strong> cellulitis
associated with purulent drainage in the absence of drainable abscess. Any
infection involving purulence is potentially attributable to <em><span
style='font-family:"Helvetica","sans-serif";font-style:normal'>MRSA</span></em>,
which should be reflected in the choice of empiric antimicrobial therapy.</span></p>
<p class=MsoNormal><b><span lang=EN-US style='color:black'>Incision and
drainage</span></b><span lang=EN-US style='color:black'> of abscess is
indicated for all purulent infections and is sufficient for <b>mild infections.</b></span></p>
<p class=MsoNormal><span lang=EN-US style='color:black'>For moderate
infections, options for oral antibiotics include the following:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='color:black'>Doxycycline 100 mg PO BD
(non-pregnant adults only), or </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-size:10.0pt;font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='color:black'>Trimethoprim-sulfamethoxazole
24 mg/kg/dose (max. 960 mg) PO BD</span></p>
<p class=MsoNormal><span lang=EN-US style='color:black'>Once microorganisms are
identified based on cultures, treatment is tailored to the patient’s need. The
most common organism are staphylococcal and streptococcal strains.</span></p>
<h3>Duration of therapy</h3>
<p class=MsoNormal><span style='color:black'>The appropriate duration of
therapy for treatment of skin and soft tissue infection depends on the nature
of the clinical presentation, and the clinical response should guide duration
of therapy.</span></p>
<p class=MsoNormal><span style='color:black'>Patients with mild infection who receive
outpatient management with oral antibiotic therapy should have repeat
evaluation after 48 hours to verify clinical response. </span></p>
<p class=MsoNormal><span style='color:black'>Patients with MRSA responsive to
oral therapy are typically treated for 5 days; treatment may be extended up to
14 days where there is severe infection, slow response to therapy, or
immunosuppression. Lack of response may be due to infection with resistant
organism(s), inadequate adherence, or presence of a deeper, more serious
infection than previously realized.</span></p>
<p class=MsoNormal><span style='color:black'>Patients with infection warranting
parenteral therapy (in the absence of bacteraemia or involvement beyond soft
tissue) are typically treated for a total duration of 5 to 14 days. Once there
are signs of clinical improvement with no evidence of systemic toxicity,
antibiotics may be transitioned from parenteral to oral therapy.</span></p>
<p class=MsoNormal><span style='color:black'>For patients with abscess that was
detected radiographically, follow-up imaging may be useful for assessing
response to therapy.</span></p>
<h2><span style='color:black'>Key Issues for Nursing care</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Ensure that patient get adequate bed
rest: Passive exercise can reduce the associated complications</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Limb elevation is important to reduce
oedema</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Pressure area care</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Cleaning any skin breaks carefully and
monitoring for signs of infection</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Advise on basic skin care and avoidance
of predisposing factors where possible</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Advise on avoidance of skin damage by wearing
appropriate protective equipment when taking part in work or sport.</span></p>
<h2><span style='color:black'>References</span></h2>
<p class=MsoNormal><span lang=EN-US><a
href="https://www.uptodate.com/contents/cellulitis-and-skin-abscess-in-adults-treatment/abstract/1"><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;text-decoration:none'>Liu
C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases
Society of America for the treatment of methicillin-resistant Staphylococcus
aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.</span></a></span></p>
<p class=MsoNormal><span lang=EN-US><a
href="https://www.uptodate.com/contents/cellulitis-and-skin-abscess-in-adults-treatment/abstract/2"><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;text-decoration:none'>Stevens
DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and
management of skin and soft tissue infections: 2014 update by the infectious
diseases society of America. Clin Infect Dis 2014; 59:147.</span></a></span></p>
<p class=MsoNormal><span lang=EN-US><a
href="https://www.uptodate.com/contents/cellulitis-and-skin-abscess-in-adults-treatment/abstract/3"><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;text-decoration:none'>Raff
AB, Kroshinsky D. Cellulitis: A Review. JAMA 2016; 316:325.</span></a></span></p>
<p class=MsoNormal><span lang=EN-US><a
href="https://www.uptodate.com/contents/cellulitis-and-skin-abscess-in-adults-treatment/abstract/4"><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;text-decoration:none'>Halilovic
J, Heintz BH, Brown J. Risk factors for clinical failure in patients
hospitalized with cellulitis and cutaneous abscess. J Infect 2012; 65:128.</span></a></span></p>
<p class=MsoNormal><span style='font-size:10.0pt'>Herchline TE. Cellulitis. Medscape
2018. Available from: </span><span lang=EN-US><a
href="https://emedicine.medscape.com/article/214222-overview"><span lang=EN-GB
style='font-size:10.0pt;color:black'>https://emedicine.medscape.com/article/214222-overview</span></a></span></p>
<p class=MsoNormal><span style='font-size:10.0pt'>John Hopkins ABX guide for
cellulitis</span></p>
<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='color:black'>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>Name: Amie Secka</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>Date: 26 November 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='color:black'>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>Name: Fatai Akemokwe</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>Date: 28 January 2019 </span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='color:black'>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='color:black'>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='color:black'>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>1.1</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>Executive summary added</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='color:black'>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='color:black'>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
<p class=MsoNormal><span style='color:black'>&nbsp;</span></p>
</div>
</body>
</html>
